08 September 2010
BIOTECHNOLOGY looks at news relating to biotech companies, their financial performance, licensing, research and merger & acquisition activities. Read wide ranging reports from around the globe, backed by a massive archive from which developments in different areas can be tracked. At this time of new legislation and activities in the area of “biosimilars: or “biogenerics” approvals, which have progressed more in Europe and are likely to impact the huge US market quite soon, watching this area will be an important aspect for subscribers and those active in the sector.7 September 2010
UK-based drug developer Silence Therapeutics (AIM: SLN) saw its share price skyrocket 76% to

7 September 2010
The European Medicines Agency (EMEA) hosted the first international scientific workshop on
3 September 2010
US biotechnology firm Seattle Genetics (Nasdaq: SGEN) has achieved a milestone under its antibody-drug
2 September 2010
The USA’s Department of Justice has appealed a district judge's ruling to ban federal funding
2 September 2010
US drug developer PDL BioPharma (Nasdaq: PDL) said yesterday that it has filed suit in a Nevada
1 September 2010
Switzerland’s active pharmaceutical ingredients and specialty chemicals firm Lonza (LONN.VX)
31 August 2010
It was a bad and a good news day yesterday for French drug major Sanofi-Aventis (Euronext;
7 September 2010 | Globes
7 September 2010 | ukcitymedia
7 September 2010 | Boston Globe
7 September 2010 | Trading Markets (press release)
6 September 2010 | Comtex Smartrend
6 September 2010 | Polish Market
6 September 2010 | stv.tv
6 September 2010 | Sydney Morning Herald
3 September 2010 | Nature.com
2 September 2010 | Financial Times
2 September 2010 | MarketWatch (press release)